LEXINGTON, Mass., Sept. 26 — RainDance Technologies, Inc., a provider of innovative droplet-based microfluidic solutions for human health and disease research, today dedicated its new headquarters and operations building and unveiled its new RDT 1000 instrument. Keynoting the event was Sir Richard Roberts, 2003 Nobel Prize winner for physiology and medicine and Founder and Chief […]
Fluidigm Corporation today announced that due to the historic instability in the market, the company is withdrawing its registration statement for its initial public offering of shares of common stock. “We went out on September 5th with a very strong story and Fluidigm received a warm reception from the investment community. We explained how our […]
– Development of next generation of High-Throughput Screening to accelerate the drug discovery process – Paris, September 26, 2008 – Sanofi-aventis announced today the launch of the dScreen Consortium, a research initiative conducted with RainDance Technologies , Inc., Lexington, Massachusetts, and Louis Pasteur University, Strasbourg, France, to develop the next generation of High-Throughput Screening (HTS) […]
Renowned separations science expert Milos Novotny, PhD, has joined Protein Discovery’s scientific advisory board. Protein Discovery will call upon Professor Novotny’s deep knowledge of electrophoretic and chromatographic separations as the company continues to develop and commercialize sample preparation systems for mass spectrometry. “Protein Discovery has commercialized electrophoretic sample preparation in a unique and immediately useful […]
New products support data security and operational qualification GE Healthcare has introduced two new products for 1-D electrophoresis gel analysis, ImageQuant™ TL SecurITy software and Installation Qualification and Operational Qualification (IQOQ) protocols. ImageQuant TL SecurITy software provides enhanced data security for analysis and documentation of 1-D electrophoresis gels by ImageQuant TL, and IQOQ offers qualification […]
MENLO PARK, Calif., Sept. 23 — ForteBio(R), Inc., a leading supplier of label-free technology that accelerates the development of life science and pharmaceutical products, today announced the closing of $25 million in Series C financing, led by OrbiMed Advisors, a top global healthcare investment firm. MPM Capital also participated as a new investor in this […]
Sequenom, Inc. (Nasdaq: SQNM) today announced that it has secured exclusive rights to fundamental patent rights for digital PCR technologies and methods through a licensing agreement with Genomic Nanosystems, LLC, a wholly owned subsidiary of the Cytonix Corporation. The exclusively licensed rights include United States Patent Nos. 6,143,496 and 6,391,559 and pending applications. The license […]
GWC Technologies Inc. today announced an agreement with Cybeles Life Science under which Cybeles will distribute GWC’s label-free array systems in South East Asia. GWC’s products are used in proteomics analysis, drug discovery research and diagnostics development. A key distinction of GWC’s analysis systems is their superior throughput and greater experimental rigor, which results from […]
New software supports screening, confirmation and characterization of anti-drug antibodies GE Healthcare announced today that it is has introduced a new immunogenicity software package for its Biacore™ T100 label-free protein interaction analysis system, to support screening, confirmation and characterization of anti-drug antibodies during preclinical and clinical development. Biacore T100 Immunogenicity Package addresses the problem of […]
DUBLIN, Calif., Sept. 17 — Microchip Biotechnologies, Inc. (MBI) has been awarded a $625,000 contract under the inaugural US Army Commercialization Pilot Program for the development of a Universal Sample Preparation Module (USPM). The Commercialization Pilot Program is a new program to assist SBIR firms that have Phase II projects that meet high priority Army […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
